Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Beijing Biotech
Parabilis Medicines, Inc.
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Essen Biotech
St. Jude Children's Research Hospital
Jonsson Comprehensive Cancer Center
xCures
Dysplasia Diagnostics Limited
Mayo Clinic
Mayo Clinic
Degron Therapeutics Co.
GlaxoSmithKline
St. Jude Children's Research Hospital
Milton S. Hershey Medical Center
Massive Bio, Inc.
Massachusetts General Hospital
Jonsson Comprehensive Cancer Center
Telix Pharmaceuticals (Innovations) Pty Limited
University of Michigan Rogel Cancer Center
Children's National Research Institute
Children's National Research Institute
National Cancer Institute (NCI)
University of Florida
Celgene
Novo Nordisk A/S
Children's National Research Institute
Celgene
Fudan University
Gilead Sciences
Shenzhen BinDeBio Ltd.
SpeciCare
Jiujiang University Affiliated Hospital
Polaris Group
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Shenzhen BinDeBio Ltd.
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Chang Gung Memorial Hospital
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Angiochem Inc
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)